Novel treatment options for transfusional iron overload in patients with myelodysplastic syndromes. [electronic resource]
Producer: 20080307Description: S16-22 p. digitalISSN:- 0145-2126
- Benzoates -- therapeutic use
- Deferasirox
- Deferiprone
- Drug-Related Side Effects and Adverse Reactions
- Humans
- Iron Chelating Agents -- adverse effects
- Iron Overload -- drug therapy
- Myelodysplastic Syndromes -- therapy
- Pyridones -- adverse effects
- Survival Rate
- Transfusion Reaction
- Treatment Outcome
- Triazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.